Gene therapy by the numbers – BioPharma Dive
|
Gene therapy by the numbers
BioPharma Dive Gene therapies have been in clinical development for decades, a winding, stop-and-start path toward transforming science's understanding of the genome into commercial therapies. Strimvelis, a gene therapy made by the British pharma GlaxoSmithKline and … |
